Grifols Sa Stock Key Fundamental Indicators
| GIFLFDelisted Stock | USD 13.90 0.00 0.00% |
Grifols SA technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Grifols SA's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Grifols SA's valuation are provided below:Grifols SA does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Grifols |
Search Suggestions
| G | Genpact Limited | Company |
| GMBLP | Esports Entertainment Group | Company |
| GF | New Germany Closed | Fund |
| GK | AdvisorShares Gerber Kawasaki | ETF |
| GVZ | CBOE Gold Volatitity | Index |
| GO | GO | Cryptocurrency |
| G91139AL2 | TAISEM 4625 22 JUL 32 | Corporate Bond |
| GCUSD | Gold Futures | Commodity |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Grifols SA has a Profit Margin of 0.0115%. This is 100.1% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The profit margin for all United States stocks is 100.91% lower than that of the firm.
Grifols SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grifols SA's current stock value. Our valuation model uses many indicators to compare Grifols SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grifols SA competition to find correlations between indicators driving Grifols SA's intrinsic value. More Info.Grifols SA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.85 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Grifols SA is roughly 1.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Grifols SA's earnings, one of the primary drivers of an investment's value.Grifols Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Grifols SA's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Grifols SA could also be used in its relative valuation, which is a method of valuing Grifols SA by comparing valuation metrics of similar companies.Grifols SA is currently under evaluation in profit margin category among its peers.
Grifols Fundamentals
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 16.07 B | |||
| Shares Outstanding | 422.18 M | |||
| Shares Owned By Insiders | 30.57 % | |||
| Shares Owned By Institutions | 30.49 % | |||
| Price To Earning | 9.52 X | |||
| Price To Book | 1.04 X | |||
| Price To Sales | 1.34 X | |||
| Revenue | 4.93 B | |||
| Gross Profit | 1.96 B | |||
| EBITDA | 944.03 M | |||
| Net Income | 182.8 M | |||
| Cash And Equivalents | 549.09 M | |||
| Cash Per Share | 0.81 X | |||
| Total Debt | 6.1 B | |||
| Debt To Equity | 1.14 % | |||
| Current Ratio | 2.68 X | |||
| Book Value Per Share | 9.32 X | |||
| Cash Flow From Operations | 596.98 M | |||
| Earnings Per Share | 0.11 X | |||
| Price To Earnings To Growth | 0.53 X | |||
| Number Of Employees | 27.58 K | |||
| Beta | 0.48 | |||
| Market Capitalization | 8.7 B | |||
| Total Asset | 19.23 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.38 % | |||
| Net Asset | 19.23 B |
About Grifols SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Grifols SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grifols SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grifols SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 27584 people.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Grifols Pink Sheet
If you are still planning to invest in Grifols SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Grifols SA's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |